Literature DB >> 12755592

Studies of chemical selectivity of hapten, reactivity, and skin sensitization potency. 3. Synthesis and studies on the reactivity toward model nucleophiles of the 13C-labeled skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI).

Rubén Alvarez-Sánchez1, David Basketter, Camilla Pease, Jean-Pierre Lepoittevin.   

Abstract

The skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI), have been synthesized isotopically labeled with (13)C at all carbon positions. The reactivity of 3-[(13)C]-, 4-[(13)C]-, and 5-[(13)C]MCI and MI toward a series of model nucleophiles for protein amino acid residues, i.e., butylamine, imidazole, sodium propanethiolate, and sodium phenoxide, was followed by (13)C and (1)H[(13)C] NMR spectroscopy. While MCI was found to react quantitatively with sodium propanethiolate and butylamine and significantly with imidazole and sodium phenoxide, MI reacted only with sodium propanethiolate. Reaction of MCI with nonthiol nucleophiles proceeded through an initial addition-elimination at position 5, leading to stable substitution adducts in the case of imidazole and sodium phenoxide. In the case of butylamine, the initial adduct was subjected to extra reactions at the sulfur atom through a cleavage of the S-N bond, leading to open adducts of the thioamide or amide type. Experiments carried out with N-acetyl-Cys, in excess or in deficiency, indicated that thiol nucleophiles reacted first at the sulfur atom through a cleavage of the S-N bond followed by extra nucleophilic reactions leading to open adducts of the mercaptothioester or mercaptoester type. Reaction of MCI with thiol nucleophiles gave products consistent with the formation of a reactive thioacyl chloride intermediate able to react with other nucleophiles present in the reaction medium. As a consequence, N-acetyl-Cys was found to be able to activate MCI toward N(alpha)-acetyl-Lys under physiological conditions to form adducts of the thioamide or amide type. Thus MCI, a strong sensitizer, and MI, a weak sensitizer, were found to react with different nucleophiles through different mechanisms. Although both MCI and MI can react with thiol nucleophiles, only MCI is capable of significantly reacting with amino nucleophiles of the Lys or His type. Moreover, MCI could be activated by a prior reaction with thiols.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12755592     DOI: 10.1021/tx0256634

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  6 in total

1.  A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors.

Authors:  A R King; A Lodola; C Carmi; J Fu; M Mor; D Piomelli
Journal:  Br J Pharmacol       Date:  2009-05-26       Impact factor: 8.739

Review 2.  Idiosyncratic adverse drug reactions: current concepts.

Authors:  Jack Uetrecht; Dean J Naisbitt
Journal:  Pharmacol Rev       Date:  2013-03-08       Impact factor: 25.468

3.  Subcutaneous Toxicity of Agmatine in Rats.

Authors:  Tayfun Uzbay; Fatma Duygu Kaya Yertutanol; Ahmet Midi; Burcu Çevreli
Journal:  Turk J Pharm Sci       Date:  2017-08-15

4.  Determination of Protein Haptenation by Chemical Sensitizers Within the Complexity of the Human Skin Proteome.

Authors:  Erika Parkinson; Maja Aleksic; Richard Cubberley; Gushinder Kaur-Atwal; Johannes P C Vissers; Paul Skipp
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

5.  Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A.

Authors:  Roberta Pacifico; Nunzio Del Gaudio; Guglielmo Bove; Lucia Altucci; Lydia Siragusa; Gabriele Cruciani; Menotti Ruvo; Rosa Bellavita; Paolo Grieco; Mauro F A Adamo
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

6.  Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.

Authors:  Todd Bosanac; Robert O Hughes; Thomas Engber; Rajesh Devraj; Andrew Brearley; Kerstin Danker; Kenneth Young; Jens Kopatz; Melanie Hermann; Antoine Berthemy; Susan Boyce; Jonathan Bentley; Raul Krauss
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.